r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

SR

Simon Read

Insider · Director · DNTH

Simon Read files insider transactions with the SEC as a director of Dianthus Therapeutics, Inc. /DE/ (DNTH). We hold 2 disclosed purchases and sales filed since 3 February 2017, 2 of them in the last 90 days.

  • Files forDNTH
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure19 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 22 May 2025 — 19 August 2026Director · Dianthus Therapeutics, Inc. /DE/ (DNTH)13 Form 4 lines · source: SEC Form 4
  • Filed 1 February 2017 — 2 April 2020Chief Scientific Officer · Ra Pharmaceuticals (RARX)37 Form 4 lines · source: SEC Form 4

Everything they disclosed

50 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.